by Aegis Biopharmaceuticals Inc.

Enhanced Health Utilizing Nature's Power

A leader in Plant-tech for Optimal and Comprehensive Health Solutions

It's not magic. It's super natural.

Modulating Your Overall Health

Our proprietary biotechnology, PHYTO-P™, leverages the SAFEST & MOST NATURAL method for overall health benefits. It is based on food-grade plants and developed by optimizing the plant's metabolic pathways, leading to a substantial and consistent improvement in various biologically active components with a pronounced effect on the human immune system. PHYTO-P™ has created a new platform for health biotechnology.

Enhance Your Wellbeing

Supplements

Supplements

Super immune system booster with 100% natural plant-derived polyphenolic complex

>>>
Wound Care

Wound Care

Achieving a series of revolutionary breakthroughs in wound healing

Coming Soon
Dermatology

Dermatology

Provides a Groundbreaking Solution for Atopic Dermatitis

Coming Soon
Skin Care

Skin Care

Remarkable skincare efficacy with 100% vegan & natural ingredients

Coming Soon

About us

AEGIS was established in 2021, headquartered in British Columbia, Canada. We possess a top-tier botanical medicine expert team and created a new platform for health biotechnology. Our experts apply precise quantitative & qualitative analysis and unique advanced extraction techniques, achieving a series of revolutionary breakthroughs in the health industry.

Our holding company is SignalChem Lifesciences Crop. (SLC), a leader in the global research and development of Protein Kinase Engineering. SLC has more than 20 years of partnerships with many world-leading pharmaceutical companies. In 2019, SLC was one of the Covid-19 drug development companies designated by the Canadian government.

Form a Partnership with us!

Submit your query using this contact form, and we'll get back to you ASAP.

 

The patent application for protecting our core technology and related technology applications has been submitted to the United States Patent and Trademark Office.

Please feel free to contact us to learn more information on the cases and progress if interested. All cases and data support investor and third-party verification.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.